Zhende Medical (China) Performance
| 603301 Stock | 79.28 0.18 0.23% |
Zhende Medical holds a performance score of 37 on a scale of zero to a hundred. The firm maintains a market beta of -0.12, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Zhende Medical are expected to decrease at a much lower rate. During the bear market, Zhende Medical is likely to outperform the market. Use Zhende Medical Co semi deviation, coefficient of variation, and the relationship between the mean deviation and downside deviation , to analyze future returns on Zhende Medical Co.
Risk-Adjusted Performance
High
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Zhende Medical Co are ranked lower than 37 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Zhende Medical sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0082 | Payout Ratio 0.6132 | Last Split Factor 1.4:1 | Forward Dividend Rate 0.65 | Ex Dividend Date 2025-06-11 |
1 | Former hot stocks surge for 9 consecutive days Financing balance spikes 8 times in 2 months - | 10/15/2025 |
| Begin Period Cash Flow | 1 B |
Zhende |
Zhende Medical Relative Risk vs. Return Landscape
If you would invest 2,428 in Zhende Medical Co on August 31, 2025 and sell it today you would earn a total of 5,500 from holding Zhende Medical Co or generate 226.52% return on investment over 90 days. Zhende Medical Co is generating 2.1227% of daily returns and assumes 4.4792% volatility on return distribution over the 90 days horizon. Simply put, 40% of stocks are less volatile than Zhende, and 58% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Zhende Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Zhende Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Zhende Medical Co, and traders can use it to determine the average amount a Zhende Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.4739
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | 603301 | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.48 actual daily | 40 60% of assets are more volatile |
Expected Return
| 2.12 actual daily | 42 58% of assets have higher returns |
Risk-Adjusted Return
| 0.47 actual daily | 37 63% of assets perform better |
Based on monthly moving average Zhende Medical is performing at about 37% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Zhende Medical by adding it to a well-diversified portfolio.
Zhende Medical Fundamentals Growth
Zhende Stock prices reflect investors' perceptions of the future prospects and financial health of Zhende Medical, and Zhende Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Zhende Stock performance.
| Return On Equity | 0.0491 | ||||
| Return On Asset | 0.0247 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 21.4 B | ||||
| Shares Outstanding | 265.84 M | ||||
| Price To Book | 3.70 X | ||||
| Price To Sales | 4.88 X | ||||
| Revenue | 4.26 B | ||||
| Gross Profit | 1.41 B | ||||
| EBITDA | 554.55 M | ||||
| Net Income | 385.17 M | ||||
| Total Debt | 266.72 M | ||||
| Book Value Per Share | 21.41 X | ||||
| Cash Flow From Operations | 461.14 M | ||||
| Earnings Per Share | 1.06 X | ||||
| Total Asset | 7.58 B | ||||
| Retained Earnings | 3.38 B | ||||
About Zhende Medical Performance
By analyzing Zhende Medical's fundamental ratios, stakeholders can gain valuable insights into Zhende Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Zhende Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Zhende Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Zhende Medical is entity of China. It is traded as Stock on SHG exchange.Things to note about Zhende Medical performance evaluation
Checking the ongoing alerts about Zhende Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Zhende Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Zhende Medical appears to be risky and price may revert if volatility continues | |
| Zhende is showing solid risk-adjusted performance over 90 days | |
| About 64.0% of the company shares are owned by insiders or employees |
- Analyzing Zhende Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Zhende Medical's stock is overvalued or undervalued compared to its peers.
- Examining Zhende Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Zhende Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Zhende Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Zhende Medical's stock. These opinions can provide insight into Zhende Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Zhende Stock analysis
When running Zhende Medical's price analysis, check to measure Zhende Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zhende Medical is operating at the current time. Most of Zhende Medical's value examination focuses on studying past and present price action to predict the probability of Zhende Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zhende Medical's price. Additionally, you may evaluate how the addition of Zhende Medical to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |